Live attenuated vaccines: Influenza, rotavirus and varicella zoster virus

4Citations
Citations of this article
19Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Since vaccinia virus was first used to protect against smallpox in the eighteenth century, live attenuated vaccines have proved to be highly effective in reducing the morbidity and mortality caused by many human viral pathogens. Contemporary live viral vaccines are designed using several different strategies to achieve attenuation. These basic principles and approaches are illustrated by vaccines to prevent rotavirus, influenza and varicella-zoster virus infections that are described in this chapter. As shown from the experience with these three vaccines, contemporary live attenuated viral vaccines have had a major impact on disease caused by these ubiquitous human pathogens. © Springer Basel AG 2011.

Cite

CITATION STYLE

APA

Greenberg, H. B., & Arvin, A. M. (2011). Live attenuated vaccines: Influenza, rotavirus and varicella zoster virus. Birkhauser Advances in Infectious Diseases, 15–46. https://doi.org/10.1007/978-3-0346-0277-8_2

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free